Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-19

Clinical Trial Update: Etanercept for the Treatment of Lupus Nephritis [Phase 2]

View source ↗

Summary

A Phase 2 trial of etanercept for lupus nephritis was terminated and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ENBREL (etanercept)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Lupus Nephritis | Phase 2 | Status: TERMINATED | Results posted: 2011-12-19